POD-AOC-01Discovery
Metabolic kidney disease
An oligonucleotide candidate program for metabolic kidney disease.
- Target
- Undisclosed
- Modality
- Oligonucleotide therapeutic
01THERAPEUTIC R&D
AOC · OLIGONUCLEOTIDE THERAPEUTICS
AOC oligonucleotide therapeutics
for kidney diseases
We are building oligonucleotide design, delivery and screening capabilities for kidney diseases, creating an R&D loop from candidate design to animal validation.
POD-AOC-02Animal validation
Viral infection after kidney transplantation
An oligonucleotide candidate program for viral infection after kidney transplantation.
- Target
- Undisclosed
- Modality
- Oligonucleotide therapeutic
Design–experiment loop
Experimental screening and pharmacology data flow back into internal design models to inform the next round of candidate selection.